Zoetis Inc.
A maker of medicines, vaccines, and diagnostics for animals, Zoetis sells well-known products like the dog itch-relief drugs Apoquel and Cytopoint and Simparica parasite preventives to veterinarians worldwide. Born in the 1950s as the animal health arm of Pfizer, it became a fully independent company in 2013. Its name comes from the Greek word "zoe," meaning life—a fitting nod to its mission of keeping animals healthy.
Granted 39.1K · Sold 20.0K
Granted 1.6K · Bought 3.0K
Granted 1.6K · Bought 2.0K
Granted 4.8K
Bought 6.7K
Granted 13.7K
Granted 1.6K
Granted 1.9K
Granted 1.6K
Granted 868
Granted 1.6K
Granted 2.1K
Granted 1.6K
Granted 1.6K
Granted 2.0K
Granted 1.5K
Granted 855
Granted 1.6K
Granted 454
Granted 1.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Peck Kristin CChief Executive Officer, Director · 9 transactions | +11.5% | 105.9K | 39.1K | — | 20.0K |
| McCallister Michael BDirector · 4 transactions | — | 39.3K | 1.6K | 3.0K | — |
| Bisaro PaulDirector · 2 transactions | +14.9% | 27.9K | 1.6K | 2.0K | — |
| Joseph WettenyChief Financial Officer · 6 transactions | +14.1% | 22.8K | 4.8K | — | — |
| Damelio Frank ADirector · 1 transaction | +44.9% | 21.5K | — | 6.7K | — |
| Parent Louise MDirector · 4 transactions | +15.8% | 18.2K | 13.7K | — | — |
| Norden GregoryDirector · 3 transactions | +7.2% | 18.2K | 1.6K | — | — |
| Lagano RoxanneExecutive Vice President · 7 transactions | +3.3% | 16.5K | 1.9K | — | — |
| Reed Willie MDirector · 1 transaction | +14.4% | 12.9K | 1.6K | — | — |
| Driscoll RimmaExecutive Vice President · 6 transactions | +11.3% | 5.9K | 868 | — | — |
| Leatherberry Antoinette ReneeDirector · 2 transactions | +29.8% | 5.3K | 1.6K | — | — |
| Brannan JamieExecutive Vice President · 6 transactions | +66.1% | 4.3K | 2.1K | — | — |
| Broadhurst VanessaDirector · 2 transactions | +39.1% | 3.9K | 1.6K | — | — |
| Hattersley GavinDirector · 2 transactions | +51.4% | 3.4K | 1.6K | — | — |
| Sarbaugh KeithExecutive Vice President · 6 transactions | +64.1% | 3.3K | 2.0K | — | — |
| Ashton NicholasExecutive Vice President · 6 transactions | +102.4% | 2.2K | 1.5K | — | — |
| Ferran Astorga JeannetteExecutive Vice President · 6 transactions | +55.1% | 1.9K | 855 | — | — |
| Stetter MarkDirector · 1 transaction | — | 1.6K | 1.6K | — | — |
| Esch KevinExecutive Vice President · 8 transactions | — | 1.1K | 454 | — | — |
| Fuller JulieExecutive Vice President · 4 transactions | +1108% | 1.1K | 1.5K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -8.3K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.